<DOC>
	<DOC>NCT03092843</DOC>
	<brief_summary>Investigators aim to assess changes in exercise capacity and quality of life after septal myectomy in patient with hypertrophic cardiomyopathy.</brief_summary>
	<brief_title>Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM</brief_title>
	<detailed_description>The objective of this study is to examine change in quality of life and functional capacity as respectively measured by, Quality of Life Questionnaires and six-minute walk test distance, following septal myectomy in patients with obstructive hypertrophic cardiomyopathy, as compared to prior to surgery.</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
	<criteria>Scheduled to undergo septal myectomy. Established diagnosis of obstructive HCM defined as: LVH Thickness ≥15mm left ventricular outflow tract gradient ≥50mmHg Prior septal myectomy or alcohol septal ablation Prior myocardial infarction Uncontrolled arrhythmias including ventricular tachycardia and atrial fibrillation Uncontrolled hypertension Angiographically documented coronary stenosis &gt;50%, if available at time of screening Inability to provide informed consent Inability to walk without assistive devices Peripheral artery disease with claudication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>